Long-term Follow-up of Participants Treated With Galapagos Chimeric Antigen Receptor (CAR) T-cell Therapies
Trial details
- Registry ID
- NCT06652633
- Phase
- Phase 3
Drug identity has not yet been verified against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Long-term Follow-up of Participants Treated With Galapagos Chimeric Antigen Receptor (CAR) T-cell TherapiesNCT06652633 | LKFT | Phase 3 | Recruiting | 2039-07Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |